Home Cart Sign in  
Chemical Structure| 112-80-1 Chemical Structure| 112-80-1

Structure of Oleic acid
CAS No.: 112-80-1

Chemical Structure| 112-80-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is also used as an activator of Na+/K+ ATPase.

Synonyms: 9-cis-Octadecenoic acid; 9Z-Octadecenoic acid; D 100

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Xu, Jeff ; Huang, Conan ; Keating, Logan ; Duan, Yunpei ; Shim, Moonsub ; Kenis, Paul JA

Abstract: Colloidal semiconductor nanocrystals or quantum dots (QDs) are a class of materials with size and shape-dependent optoelectronic properties that show potential for a range of applications. Discovery of new QDs with interesting properties and optimization of their synthesis require a rapid, generalizable, and scalable purification method to separate QDs from reaction mixtures. This paper describes a size-exclusion chromatography (SEC)-based approach that enables rapid, efficient separation of QDs from crude QD reaction mixtures. Using commercially available C-18 capped silica columns and off-the-shelf components, we report an automated liquid-chromatography platform with integrated optical characterization (UV-Vis) for in-line optical characterization. This platform was used to investigate the effects of column operating parameters on QD separation performance and was further validated using six crude QD samples of different sizes, shapes, and compositions. Ligand coverage of the purified QD fractions can be tuned by controlling column parameters, with higher temperatures and residence times leading to ligand shedding of QDs. NMR analysis of purified QDs showed reduced solvent and ligand impurities when compared to samples purified using precipitation-redissolution method. This SEC method provides a rapid (< 2 mins) approach for one-step purification of crude QDs on analytical or preparative scales and can be seamlessly integrated into existing QD or other nanocrystal research workflows.

Purchased from AmBeed:

Alternative Products

Product Details of Oleic acid

CAS No. :112-80-1
Formula : C18H34O2
M.W : 282.46
SMILES Code : CCCCCCCC/C=C\CCCCCCCC(O)=O
Synonyms :
9-cis-Octadecenoic acid; 9Z-Octadecenoic acid; D 100
MDL No. :MFCD00064242
InChI Key :ZQPPMHVWECSIRJ-KTKRTIGZSA-N
Pubchem ID :445639

Safety of Oleic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 300 mM 24 hours To investigate the effect of apelin/APLNR on hepatic lipid accumulation. Results showed that apelin/APLNR did not directly affect lipid metabolism in hepatocytes. Int J Med Sci. 2025 Jan 1;22(1):197-208.
L02 cells 400 µM 2 and 5 days To evaluate the cytotoxicity and lipid droplet accumulation effects of OA on L02 cells. Results showed that OA had no significant cytotoxicity in 2 days but slight cytotoxicity at 400 µM in 5 days. Lipid droplet accumulation increased in a time-dependent manner within 5 days. Int J Mol Sci. 2024 May 7;25(10):5086.
HepG2 cells 400 µM 2 and 5 days To evaluate the cytotoxicity and lipid droplet accumulation effects of OA on HepG2 cells. Results showed that OA had no significant cytotoxicity in 2 days but slight cytotoxicity at 400 µM in 5 days. Lipid droplet accumulation increased in a time-dependent manner within 5 days. Int J Mol Sci. 2024 May 7;25(10):5086.
H1299 20 nM 48 hours To evaluate the effect of OA on radioresistant cells, OA pretreatment significantly reduced radiation-induced lipid ROS and iron accumulation, increased the GSH/GSSG ratio, and protected cells from radiation-induced ferroptosis. Cell Death Dis. 2025 Mar 18;16(1):184
A549 20 nM 48 hours To evaluate the effect of OA on radioresistant cells, OA pretreatment significantly reduced radiation-induced lipid ROS and iron accumulation, increased the GSH/GSSG ratio, and protected cells from radiation-induced ferroptosis. Cell Death Dis. 2025 Mar 18;16(1):184
CMT93 20 nM 48 hours To evaluate the effect of OA on radioresistant cells, OA pretreatment significantly reduced radiation-induced lipid ROS and iron accumulation, increased the GSH/GSSG ratio, and protected cells from radiation-induced ferroptosis. Cell Death Dis. 2025 Mar 18;16(1):184
SW837 20 nM 48 hours To evaluate the effect of OA on radioresistant cells, OA pretreatment significantly reduced radiation-induced lipid ROS and iron accumulation, increased the GSH/GSSG ratio, and protected cells from radiation-induced ferroptosis. Cell Death Dis. 2025 Mar 18;16(1):184
DRG neurons 5 μM 5 min Inhibited capsaicin-activated currents by 86.6±4% Nat Commun. 2016 Oct 10;7:13092.
HEK293 cells 5 μM 5 min Inhibited thermally activated TRPV1 currents by 72±8% Nat Commun. 2016 Oct 10;7:13092.
AML12 cells 400 μM 18 hours AGPAT2 deficiency led to the formation of giant LDs Nat Commun. 2021 Nov 25;12(1):6877.
LY2 cells 100 μmol/L 24 hours To evaluate the effect of oleic acid and fenofibrate on LY2 cell viability, results showed increased intrinsic cancer cell toxicity upon treatment with FF or OA. Clin Cancer Res. 2024 May 1;30(9):1916-1933.
MOC2 cells 100 μmol/L 24 hours To evaluate the effect of oleic acid and fenofibrate on MOC2 cell viability, results showed increased intrinsic cancer cell toxicity upon treatment with FF or OA. Clin Cancer Res. 2024 May 1;30(9):1916-1933.
Vascular smooth muscle cells (VSMC) 2.5 μmol/L 10 minutes To evaluate the effect of OA-NO2 on Ang II-induced IP3 production and calcium mobilization, results showed OA-NO2 inhibits Ang II-induced IP3 production and calcium mobilization Circ Res. 2010 Aug 20;107(4):540-8.
HEK293 cells 5 μmol/L 3 hours To detect covalent binding of OA-NO2 to AT1R, results showed OA-NO2 forms covalent adducts with AT1R Circ Res. 2010 Aug 20;107(4):540-8.
Human Dermal Micovasvular Endothelial Cells (HDMEC) 1mM Overnight HDMEC were cultured on transwell inserts to form compact monolayers. OA loading induced LD formation. In the experiment, LD-rich HDMEC were co-cultured with differentiated C2C12 myotubes, and free fatty acid release was detected. Circ Res. 2017 Apr 14;120(8):1289-1297.
EA.hy 926 cells 1mM Overnight In EA.hy 926 cells, RT-qPCR analysis showed that only PLN2 and PLN3 among the 5 known perilipins (PLN) were expressed. Subcellular fractionation revealed that LD fractions were enriched with PLN2, PLN3, and lipolytic enzymes including ATGL and its co-activator CGI-58. Circ Res. 2017 Apr 14;120(8):1289-1297.
Mouse lung endothelial cells (MLEC) 1mM 24 hours OA-induced LD formation in MLEC was time- and dose-dependent, reaching maximum cellular TG content (285.86±41.05 nmol TG/mg protein) after 24 hours. OA supplementation increased mRNA levels of TG synthetic enzymes including GPAT4, AGPAT2, Lipin2, DGAT1, and DGAT2. Circ Res. 2017 Apr 14;120(8):1289-1297.
Mouse melanoma cells 500 μM 12 hours Oleic acid protected melanoma cells from Erastin-induced ferroptosis Nature. 2020 Sep;585(7823):113-118.
Human melanoma cells 500 μM 12 hours Oleic acid protected melanoma cells from Erastin-induced ferroptosis Nature. 2020 Sep;585(7823):113-118.
Human Dermal Microvascular Endothelial Cells (HDMEC) 1mM Overnight To study lipid droplet formation and fatty acid release, results showed that OA treatment induced lipid droplet formation and fatty acid release was affected by inhibition of ATGL and HSL. Circ Res. 2017 Apr 14;120(8):1289-1297.
EA.hy 926 cells 1mM Overnight To study the expression of lipid droplet-associated proteins, results showed that PLN2 and PLN3 were expressed in EA.hy 926 cells and enriched in the lipid droplet fraction. Circ Res. 2017 Apr 14;120(8):1289-1297.
Mouse lung endothelial cells (MLEC) 1mM 24 hours To study oleic acid-induced lipid droplet formation and its time-dependence, results showed that cellular triglyceride content reached maximum after 24 hours of OA treatment. Circ Res. 2017 Apr 14;120(8):1289-1297.
Primary hepatocytes 2 mM 8 hours To evaluate OA-induced lipid accumulation and the alleviating effect of metformin. Results showed that OA significantly increased intracellular lipid accumulation, while metformin pretreatment significantly attenuated OA-induced lipid accumulation. Autophagy. 2015;11(1):46-59.
HepG2 cells 1 mM 8 hours To evaluate OA-induced lipid accumulation and the alleviating effect of metformin. Results showed that OA significantly increased intracellular lipid accumulation, while metformin pretreatment significantly attenuated OA-induced lipid accumulation. Autophagy. 2015;11(1):46-59.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57Bl/6 mice Acute lung injury model Intravenous injection 0.15 µl/g Single dose, observed for 24 hours Oleic acid caused severe alveolar damage with the development of alveolar edema of the increased-permeability type with associated abnormalities in gas exchange. When given together with endotoxin, they acted synergistically to increase pulmonary edema and to worsen gas exchange and hemodynamics, thereby increasing mortality. Am J Respir Crit Care Med. 2005 Aug 1;172(3):344-51
C57BL/6 mice Fasted mice gavaged with olive oil Oral gavage 10mL/kg Single gavage, observation time points included 90 mins, 180 mins, and 270 mins To study the dynamics of oleic acid-induced lipid droplet formation and degradation, results showed that plasma triglyceride levels peaked at 90 mins post-gavage, lipid droplets were prominent in aortic endothelial cells at 180 mins, and degraded by 270 mins. Circ Res. 2017 Apr 14;120(8):1289-1297.
Mice Pain and itch models Plantar injection 3.1 μg/10 μl Single injection, observed for 10 min Significantly reduced pain responses induced by capsaicin and LPA Nat Commun. 2016 Oct 10;7:13092.
Mice Ang II-induced hypertension model Subcutaneous implantation of osmotic mini-pumps 5 mg/kg/day 14 days To evaluate the effect of OA-NO2 on Ang II-induced hypertension, results showed OA-NO2 significantly reduces Ang II-induced hypertension Circ Res. 2010 Aug 20;107(4):540-8.
NSG mice Patient-derived melanomas Intravenous injection 500 μM Single injection, observed for 1-3 months Pre-treatment with oleic acid significantly increased the metastatic potential of melanoma cells in the blood Nature. 2020 Sep;585(7823):113-118.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02646202 Gastroesophageal Varices Phase 3 Recruiting December 2021 Egypt ... More >> Tropical medicine dept.-Tanta university hospital Recruiting Tanta, Egypt Contact: Sherief Abd-Elsalam       Sherif_tropical@yahoo.com Less <<
NCT02049034 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> University of Surrey FHMS Diabetes and Metabolic Medicine Guildford, Surrey, United Kingdom, GU2 7WG Less <<
NCT01931826 Schistosomiasis Mansoni ... More >> Portal Hypertension Upper Gastrointestinal Bleeding Less << Not Applicable Completed - Brazil ... More >> Universidade Federal de Alagoas Maceio, Alagoas, Brazil, 57000000 Less <<
NCT02166359 End Stage Renal Disease Not Applicable Recruiting December 2020 Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of Less <<
NCT01174511 ATOPIC DERMATITIS Phase 1 Phase 2 Unknown November 2012 -
NCT00721617 Diabetes Hype... More >>rtension Obesity Less << Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT03201588 Ophthalmological Disorder Not Applicable Recruiting December 31, 2019 Sweden ... More >> Queen Silvias Childrens Hospital Recruiting Göteborg, Sweden, 41650 Contact: Karin Savman, MD,PhD    +46 ext 739940937    karin.savman@vgregion.se    Contact: Svetlana Najm, MD    +46 ext 738999992    svatlana.najm@vgregion.se    Skanes Universitetssjukhus Recruiting Lund, Sweden Contact: David Ley, Professor    +46 ext 709264824    david.ley@med.lu.se    Contact: Ingrid Pupp, MD,PhD    +46 ext 761712021    ingrid.pupp@med.lu.se    KI Recruiting Stockholm, Sweden, 14157 Contact: Boubou Hallberg, MD.PhD    +46 ext 700021010    boubou.hallberg@karolinska.se    Contact: Dirk Wackernagel, MD    +46 ext 700011758    dirk.wackernagel@karolinska.se Less <<
NCT00721617 - Completed - -
NCT01733147 Barrett's Esophagus ... More >> Obesity Less << Phase 4 Recruiting December 2018 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Michele L Johnson    507-255-8692    johnson.michele@mayo.edu Less <<
NCT01686568 Insulin Resistance Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02229526 Preterm Birth ... More >> Intrauterine Growth Retardation Pregnancy Induced Hypertension Less << Not Applicable Completed - -
NCT02264951 Type 2 Diabetes Not Applicable Completed - -
NCT01686568 - Completed - -
NCT00873262 Premenstrual Syndrome Phase 2 Unknown November 2010 Israel ... More >> Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 64239 Contact: Shmuel Kivity, Prof.    +972-3-697-3734    allergy@tasmc.health.gov.il    Contact: Tzipi Yemini    +972-3-697-3734    zipiy@tasmc.health.gov.il    Principal Investigator: Shmuel Kivity, Prof. Less <<
NCT02537314 Obesity Phase 1 Enrolling by invitation April 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT03094247 Severe Acute Malnutrition Not Applicable Recruiting September 1, 2019 Malawi ... More >> University of Malawi College of Medicine Recruiting Blantyre, Malawi Contact: Kenneth Maleta, MBBS    +256 018 719 111    ken.maleta@gmail.com    Principal Investigator: Kenneth Maleta, MBBS          Sub-Investigator: Chrissie Thawalawka, PhD Less <<
NCT01901471 Acute Myocardial Infarction Phase 2 Withdrawn October 2015 France ... More >> CH Pays d'Aix Aix-en-Provence, France, 13616 Clinique de La Fourcade Bayonne, France, 64100 CHU Hopital Cardiologique Louis Pradel Bron, France, 69677 Hôpital Gabriel Montpied Clermont-ferrand, France, 63003 Chu Hopital Du Bocage Dijon, France, 21034 Chu Hopital A Michallon Grenoble, France, 38043 Hopital St Luc St Joseph Lyon, France Chu Arnaud de Villeneuve Montpellier, France, 34295 Hopital Guillaume Et Rene Laennec Nantes, France, 44093 Chu de Nimes Nimes, France, 30029 Aphp Hopital Bichat Paris, France, 75018 Centre Hospitalier de Pau PAU, France, 64011 Chu de Bordeaux Pessac, France, 33604 Hopital Charles Nicolle Rouen, France, 76031 Nouvel Hôpital Civil Strasbourg, France, 67091 Chu de Rangueil Toulouse, France, 31403 Chru de Tours Tours, France, 37044 Chu de Nancy Brabois Vandoeuvre Les Nancy, France, 54511 Less <<
NCT01175759 Abortion, Recurrent Phase 2 Unknown December 2011 Hungary ... More >> Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine Recruiting Budapest, Hungary, H1125 Contact: George Füst, Prof.    361-212-9351    fustge@kut.sote.hu    Principal Investigator: János Rigó, Prof.          Principal Investigator: Henriette Farkas, Prof. Less <<
NCT01020578 - Completed - Brazil ... More >> Endocrinology Service and Lipid Laboratory of Heart Institute of University of São Paulo São Paulo, Brazil Less <<
NCT00866437 Premenstrual Syndrome Phase 2 Unknown November 2010 Israel ... More >> Sheba Medical Center, Tel-Hashomer Recruiting Ramat Efal, Israel, 52621 Contact: Avner Reshef, Dr    +972-3-5302605    Avner.Reshef@sheba.health.gov.il    Contact: Iris Leibovich    +972-3-5302605    iris.leibovich@sheba.health.gov.il    Principal Investigator: Avner Reshef, Dr Less <<
NCT01010035 - Completed - Brazil ... More >> Endocrinology service and Lipid laboratory of Heart Institute of University of São Paulo São Paulo, Brazil, 05423000 Less <<
NCT02670382 Metabolic Syndrome Not Applicable Active, not recruiting April 2019 United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT02291809 HIV/AIDS Phase 2 Not yet recruiting November 2019 United States, California ... More >> Clinical Site TBA Not yet recruiting San Diego, California, United States, 92101 Contact: Richard M Bartholomew, PhD    858-414-4664    richardmbartholomew@gmail.com Less <<
NCT02647333 Cardiovascular Disease Phase 2 Completed - -
NCT02699047 Gastrointestinal Cancer ... More >> Colorectal Cancer Stomach Cancer Less << Not Applicable Unknown July 2017 Brazil ... More >> Michel Carlos Mocellin Florianopolis, Santa Catarina, Brazil Less <<
NCT03364101 Sleep Not Applicable Completed - United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT00655902 Metabolic Syndrome ... More >> Abdominal Obesity Heart Disease Type 2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT03563222 Malnutrition, Child Phase 4 Not yet recruiting November 2020 -
NCT02209298 - Active, not recruiting March 2019 France ... More >> CHU Brest Brest, France CHU Clermont Clermont-Ferrand, France CHU Mondor Créteil, France Clinique Parly 2 Le Chesnay Le Chesnay, France CHU Lille Lille, France HCL CHU Louis Pradel Lyon, France CHU La Timone Marseille, France Hopital Jacques Cartier Massy, France CHU de Nantes Nantes, France CHU La Pitié Salpétrière Paris, France CHU Bordeaux Pessac, France CHU Rennes Rennes, France CHU Rangueil Toulouse Toulouse, France Clinique Pasteur Toulouse, France Tonkin Clinic Villeurbanne, France Germany Kerckhoff Klinik Bad Nauheim, Germany Herz- und Diabeteszentrum NRW Bad Oeynhausen, Germany Sana-Herzzentrum Cottbus Cottbus, Germany Hamburg Eppendorf Hamburg, Germany Herzzentrum Leipzig GmbH Leipzig Leipzig, Germany Israel Rabin Medical center Petah Tikva, Israel Sheba Medical Center Tel Hashomer, Israel Italy Brescia Hospital Brescia, Italy Policlinico San Donato Milano, Italy Azienda Ospedaliero Universitaria Pisana Pisa, Italy Less <<
NCT03449524 PAH Phase 2 Recruiting August 2019 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35233 Contact: Jose Tallaj, MD          Contact: Patrick Frazier       thomasfrazier@uabmc.edu    United States, Arizona University of Arizona Not yet recruiting Tucson, Arizona, United States, 85724 Contact: Franz Rischard, DO          Contact: Valerie Bloss    520-626-8305       United States, California University of California San Diego Not yet recruiting La Jolla, California, United States, 92037 Contact: David Poch, MD          Contact: Jeff Terry    858-657-7141       United States, Colorado University of Colorado Health Recruiting Aurora, Colorado, United States, 80045 Contact: David Badesch, MD          Contact: Kelly Hannon    720-848-6552       National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Patricia George, MD          Contact: Kyle Pickard    303-398-1172       United States, District of Columbia Washington Hospital (Medstar) Recruiting Washington, District of Columbia, United States, 20010 Contact: Christopher Barnett, MD          Contact: Sarah Ahmed    202-877-9328       United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Tim Lahm, MD          Contact: Shawna Prange    317-962-7459       United States, Minnesota University of Minnesotta Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kurt Prins, MD          Contact: Gretchn Peichel    612-626-6237       United States, Missouri Washington University and Barnes Jewish Hospital Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Murali Chakinala, MD          Contact: Ellen Lovato    314-454-8717       United States, New York NYU Langone Medical Center Not yet recruiting New York, New York, United States, 10279 Contact: Roxana Sulica, MD          Contact: Anabela Barroso    212-263-9189       United States, North Carolina Duke University Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Sudarshan Rajagopal, MD          Contact: Amanda Kelly       amanda.kelly@duke.edu    United States, Ohio Christ Hospital-Lindner Research Center Recruiting Cincinnati, Ohio, United States, 45219 Contact: Peter Engel, MD          Contact: Tonya Brinegar    513-585-1766    tonya.brinegar@thechristhospital.com    Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Gustavo Heresi, MD          Contact: Mary Beukeman    216-444-2140       The Ohio State University Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Shaun Smith, MD          Contact: Barbara McCracken    614-366-7843       United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jeremy Mazurek, MD          Contact: Mamta Patel    215-294-9759       Allegheny General Hospital Not yet recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Raymond Benza, MD          Contact: Matthew Yeager    412-359-8468       University of Pittsburgh Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Nydia Chien, MSN,RN,CCRC    412-647-2791    chienn@upmc.edu    United States, Texas Texas Tech Not yet recruiting El Paso, Texas, United States, 79905 Contact: Hernando Garcia, DO          Contact: Hadeer Azeez    915-215-6696       Houston Methodist Not yet recruiting Houston, Texas, United States, 77030 Contact: Zeenat Safdar, MD          Contact: Ann Salino    713-441-5597       United States, Virginia University of Virginia School of Medicine Recruiting Charlottesville, Virginia, United States, 22908 Contact: Andrew Mihalek, MD          Contact: Nicolle Sprouse    434-243-6091    njb6m@virginia.edu    Sentara Medical Group Recruiting Norfolk, Virginia, United States, 23507 Contact: Michael Eggert, MD          Contact: Melinda Bullivant       mmbulliv@sentara.com Less <<
NCT02525107 Sickle Cell Disease Phase 3 Not yet recruiting March 2019 Oman ... More >> Department of Haematology, Sultan Qaboos University Recruiting Muscat, Oman, 123 Contact: Salam Alkindi, MD    +96824144947 ext 4947    sskindi@yahoo.com Less <<
NCT01841944 Myocardial Infarction ... More >> Heart Failure Myocardial Revascularization Atrial Fibrillation Less << Not Applicable Recruiting November 2019 Norway ... More >> Asker and Bærum Hospital Recruiting Rud, Bærum, Norway, 1309 Contact: Arnljot Tveit, MD Phd       arnljot.tveit@vestreviken.no    Akershus university hospital HF Recruiting Lørenskog, Norway, 1478 Contact: Pål Smith, MD Phd          Principal Investigator: Peder Myhre, MD          Oslo University Hospital(Ullevaal) Recruiting Oslo, Norway, 0424 Principal Investigator: Kristian Laake, MD Less <<
NCT01473823 Food Allergy ... More >>Eczema Sensitisation Less << Not Applicable Enrolling by invitation December 2020 Sweden ... More >> Allergicentrum Linköping, Sweden Less <<
NCT00988585 Heart Disease Phase 1 Completed - United States, Massachusetts ... More >> Cardiovascular Research Associates Boston, Massachusetts, United States, 02111 Less <<
NCT00995631 Menopause Pre... More >>-menopause Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT02410161 Healthy Phase 4 Completed - -
NCT02311686 Alcohol Consumption ... More >> Healthy Less << Phase 1 Completed - Spain ... More >> Parc de Salut Mar (IMIM) Barcelona, Spain, 08003 Less <<
NCT03680976 Asthma Phase 2 Withdrawn(The study will not t... More >>ake place at the University of Pittsburgh) Less << April 2021 United States, Pennsylvania ... More >> The University of Pittsburgh Asthma Institute at UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02631421 - Enrolling by invitation June 2019 United States, Tennessee ... More >> Vanderbilt Univeristy Nashville, Tennessee, United States, 37203 Less <<
NCT03757845 Diabetes Complications ... More >> Cardiovascular Diseases Less << Not Applicable Not yet recruiting November 2022 -
NCT02005900 HIV-associated Hypertriglyceri... More >>demia HIV-associated Hypercholesterolemia HIV-associated Inflammatory State Less << Phase 3 Completed - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Less <<
NCT00262145 Diabetes Over... More >>weight Less << Phase 1 Completed - United States, Minnesota ... More >> VA Medical Center Minneapolis, Minnesota, United States, 55417 Less <<
NCT02520739 Cardiovascular Diseases Phase 3 Unknown December 2016 Spain ... More >> University Hospital Virgen de las Nieves Granada, Spain, 18012 Less <<
NCT02312492 Dyslipidemia Not Applicable Active, not recruiting December 2018 United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT00342303 - Completed - Chile ... More >> Clinica Presbiteriana Madre Hijo Santiago, Chile Hospital Luis Tisne Santiago, Chile Less <<
NCT01665482 Inflammation ... More >>Insulin Sensitivity Less << Not Applicable Completed - Malaysia ... More >> Malaysia Palm Oil Board (MPOB) Kajang, Selangor, Malaysia, 43000 Less <<
NCT01131962 Hematemesis P... More >>ortal Hypertension Less << Phase 3 Completed - Egypt ... More >> Hematemesis unit, Alexandria Main University Hospital, Azarita Alexandria, Egypt Less <<
NCT01618071 Postprandial Period ... More >> Lipemia Vasodilation Vascular Resistance Nitric Oxide Less << Not Applicable Completed - United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London London, United Kingdom, SE1 9NH Less <<
NCT02219399 Pregnancy Not Applicable Completed - United States, Colorado ... More >> Denver Health Hospitals and Clinics Denver, Colorado, United States, 80237 Colorado State University Fort Collins, Colorado, United States, 80523 Less <<
NCT03625427 Obesity Chron... More >>ic Inflammation Less << Not Applicable Not yet recruiting November 2020 United States, North Carolina ... More >> University of North Carolina Nutrition Research Institute Not yet recruiting Kannapolis, North Carolina, United States, 28081 Contact: Jomari Torres, MD    704-250-5062    jomari_torres@unc.edu Less <<
NCT01681459 - Completed - Denmark ... More >> Hvidovre Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT02061267 Metabolic Syndrome Not Applicable Unknown December 2014 Spain ... More >> Instituto de la Grasa, CSIC Seville, Spain, 41012 Less <<
NCT00799851 Liver Disease Phase 4 Completed - Brazil ... More >> Federal University Of São Paulo - Gastroenterology São Paulo, Brazil, 04081000 Less <<
NCT02802904 Cardiovascular Risk Factor Not Applicable Completed - -
NCT02243969 Hypertension ... More >>Lipid Metabolism Disorders Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT03289559 Healthy Volun... More >>teers Less << Not Applicable Completed - -
NCT00479791 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235-9052 Less <<
NCT01674946 Echolocation Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland, 4031 Less <<
NCT03388697 - Recruiting December 15, 2019 United States, Texas ... More >> Ashley Salazar Recruiting Galveston, Texas, United States, 77555 Contact: Antonio Saad, MD    409-772-0982    afsaad@utmb.edu    Contact: Ashley Salazar    140927720312    assalaza@utmb.edu    Principal Investigator: Antonio Saad, MD          Sub-Investigator: George Saade, MD Less <<
NCT03422510 Primary Focal Segmental Glomer... More >>ulosclerosis Less << Phase 2 Recruiting July 2019 -
NCT03774095 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Recruiting December 30, 2018 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Karina Sørensen, MSc    26924602       Contact: Kurt Højlund, MD    +45 65413422 Less <<
NCT02210767 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT02397213 Acute Kidney Injury Phase 2 Completed - Sweden ... More >> Skane University Hospital Lund, Sweden, 22185 Less <<
NCT00434265 Obesity Not Applicable Completed - France ... More >> Service des Explorations Fonctionelles Respiratoires et de l'Exercice - Hôpital Civil Strasbourg, France, 67091 Service de Médecine Interne et de Nutrition - Hôpital de Hautepierre Strasbourg, France, 67098 Less <<
NCT03426592 Human Immunodeficiency Virus Phase 2 Active, not recruiting July 2019 Australia, Victoria ... More >> The Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia, 3000 The Alfred Hospital - Department of Infectious Diseases Melbourne, Victoria, Australia, 3004 Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 Melbourne Sexual Health Centre Melbourne, Victoria, Australia, 3053 Less <<
NCT02460146 Acute Kidney Injury Phase 1 Completed - United States, Michigan ... More >> Jasper Clinical Research & Development, Inc. Kalamazoo, Michigan, United States, 49007 Less <<
NCT02797483 Healthy Not Applicable Completed - -
NCT01618019 - Completed - -
NCT00529828 Healthy Not Applicable Completed - Netherlands ... More >> Wageningen University, Division of Human Nutrition Wageningen, Netherlands, 6703 HD Less <<
NCT02547402 Acute Kidney Injury Phase 1 Completed - United States, Michigan ... More >> Jasper Clinical Research & Development, Inc. Kalamazoo, Michigan, United States, 49007 Less <<
NCT01503047 Overweight Ob... More >>esity Less << Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT01351012 Metabolic Syndrome Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT00535886 Cardiovascular Disease ... More >> Diabetes Dyslipidemia Less << Not Applicable Completed - United States, California ... More >> Children's Hospital Oakland Research Institute Oakland, California, United States, 94609 Less <<
NCT03762395 Asthma Obesit... More >>y Less << Phase 2 Not yet recruiting August 2021 -
NCT01259999 Protein-Energy Malnutrition ... More >> Anorexia Weight Change Less << Not Applicable Completed - Sweden ... More >> Dep of Geriatrics, Karolinska University Hospital Stockholm, Sweden, 141 86 Less <<
NCT01618019 Rheumatoid Arthritis Not Applicable Completed - Korea, Republic of ... More >> Hanyang university hospital Seoul, Korea, Republic of, 133-792 Less <<
NCT01661764 - Completed - -
NCT01661764 Colorectal Adenomatous Polyps Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01128400 - Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02145936 Dyslipidemia Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT01128400 - Completed - -
NCT01233778 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01365078 Lipid Metabolism Disorders Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02992548 Chronic Kidney Disease Phase 4 Active, not recruiting August 2018 Korea, Republic of ... More >> Dong-A University Busan, Korea, Republic of, 602715 Inje University, Pusan Paik Hospital Busan, Korea, Republic of Less <<
NCT02863185 Chronic Kidney Disease Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Won Suk An Recruiting Busan, Korea, Republic of, 602-715 Contact: Won Suk An, M.D., Ph.D.    +82-51-240-2811    anws@dau.ac.kr    Dong-A University Not yet recruiting Busan, Korea, Republic of, 602715 Contact: Su Mi Lee, MD    +822405549    promise131@hanmail.net Less <<
NCT01066091 Healthy Obesi... More >>ty Less << Not Applicable Completed - France ... More >> Human nutrition laboratory Clermont-ferrand, Auvergne, France, 63000 Less <<
NCT02390180 - Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT03388125 Bleeding Esophageal Varices Phase 3 Active, not recruiting December 1, 2022 Egypt ... More >> Sherief Abd-Elsalam Tanta, Egypt Less <<
NCT03141931 Dry Eye Not Applicable Recruiting November 2018 Australia, New South Wales ... More >> School of Optometry and Vision Science Recruiting Sydney, New South Wales, Australia, 2052 Contact: Jacqueline Tan-Showyin, PhD    +612 9385 6551    jacqueline.tan@unsw.edu.au Less <<
NCT00927199 Cardiovascular Disease Phase 2 Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT00638196 Multiple Sclerosis Phase 1 Terminated(funding stopped due... More >> to slow enrollment.) Less << - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT02029833 Cardiovascular Disease ... More >> Diabetes Metabolic Syndrome Less << Not Applicable Completed - United States, Pennsylvania ... More >> The Pennsylvania State University University Park, Pennsylvania, United States, 16802 Canada, Manitoba St Boniface Hospital Research Winnipeg, Manitoba, Canada, R2H 2A6 Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Quebec Institute of Nutrition and Functional Foods, Laval University Quebec City, Quebec, Canada, G1V 0A6 Less <<
NCT01043445 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Department of Clinical Physiology, Glostrup Hospital Glostrup, Denmark, 2600 Less <<
NCT02993380 Hemodialysis Not Applicable Completed - Korea, Republic of ... More >> Dong-A University Busan, Seogu, Korea, Republic of, 49201 Less <<
NCT00059254 Obesity Diabe... More >>tes Hyperlipidemia Less << Not Applicable Completed - United States, Texas ... More >> Utmb Gcrc Galveston, Texas, United States, 77555 Less <<
NCT02841618 Healthy Adults Not Applicable Active, not recruiting December 2017 United States, Ohio ... More >> The Ohio State University Human Nutrition Laboratory Columbus, Ohio, United States Less <<
NCT03739463 PPROM Not Applicable Not yet recruiting May 15, 2020 -
NCT01124487 Lipid Profile Not Applicable Completed - Malaysia ... More >> Malaysian Palm Oil Board Kajang, Selangor, Malaysia, 43000 Less <<
NCT00804037 Snoring Apnea Not Applicable Unknown - Brazil ... More >> University of São Paulo São Paulo, SP, Brazil Less <<
NCT00000886 HIV Infections Phase 1 Completed - United States, New York ... More >> Univ. of Rochester AVEG Rochester, New York, United States United States, Tennessee Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States, 37232 United States, Washington UW - Seattle AVEG Seattle, Washington, United States, 98144 Less <<
NCT01612234 Obesity Not Applicable Completed - United States, Vermont ... More >> The Unversity of Vermont Clinical Research Center at Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Less <<
NCT03054779 Cardiovascular Disease ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01686113 Hypogeusia Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00715312 Inflammation Not Applicable Completed - Malaysia ... More >> Malaysia Palm Oil Board Kajang, Selangor, Malaysia, 50720 Less <<
NCT01042340 Nutritional Intervention Not Applicable Completed - Sweden ... More >> Dep of Geriatrics, Karolinska University Hospital, Huddinge Stockholm, Sweden, 141 86 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.54mL

0.71mL

0.35mL

17.70mL

3.54mL

1.77mL

35.40mL

7.08mL

3.54mL

References

 

Historical Records

Categories